NF-κB in cancer therapy

NF-κB in cancer therapy

The transcription factor nuclear factor kappa B (NF-κB) has attracted increasing attention in the field of cancer research from last few decades. Aberrant activation of this transcription factor is frequently encountered in a variety of solid tumors and hematological malignancies. NF-κB family membe...

Full description

Bibliographic Details
Main Authors:	Li, F., Zhang, J., Arfuso, Frank, Chinnathambi, A., Zayed, M., Alharbi, S., Kumar, Alan Prem, Ahn, K., Sethi, G.
Format:	Journal Article
Published:	Springer Verlag 2015
Online Access:	http://hdl.handle.net/20.500.11937/12782

Similar Items

Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-?B signaling cascade in gastric cancer
by: Manu, K., et al.
Published: (2015)

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
by: Dai, X., et al.
Published: (2015)

The multifaceted role of curcumin in cancer prevention and treatment
by: Shanmugam, M., et al.
Published: (2015)

Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
by: Nirvanappa, Anilkumar C., et al.
Published: (2016)

Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression
by: Yu Rou Puar, et al.
Published: (2018-07-01)

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
by: Siveen, K., et al.
Published: (2014)

Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics
by: Samy, R., et al.
Published: (2015)

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
by: Siveen, Kodappully Sivaraman, et al.
Published: (2013)

NF-κB in premature aging
by: Osorio, Fernando G., et al.
Published: (2012)

To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator
by: Sorriento, Daniela, et al.
Published: (2012)

The complexity of NF-κB signaling in inflammation and cancer
by: Hoesel, Bastian, et al.
Published: (2013)

Colorectal cancer and NF-κB signaling pathway
by: Hassanzadeh, Parichehr
Published: (2011)

NF-κB in Cellular Senescence and Cancer Treatment
by: Jing, Hua, et al.
Published: (2014)

Critical role of NF-κB in pancreatic cancer
by: Prabhu, Lakshmi, et al.
Published: (2014)

The NF-κB Pathway and Cancer Stem Cells
by: Rinkenbaugh, Amanda L., et al.
Published: (2016)

Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease
by: Flood, Patrick M., et al.
Published: (2011)

NF-κB and the Immunoglobulin κ Gene Enhancer
by: Sen, Ranjan
Published: (2004)

The Regulation of NF-κB Subunits by Phosphorylation
by: Christian, Frank, et al.
Published: (2016)

Investigation of NF-κB1 and NF-κBIA Gene Polymorphism in Non-Small Cell Lung Cancer
by: Oltulu, Y. M., et al.
Published: (2014)

Slow but steady for NF-κB
by: Leslie, Mitch
Published: (2012)

Keeping NF-κB in check
by: Williams, Ruth
Published: (2006)

At the crossroads of SUMO and NF-κB
by: Kracklauer, Martin P, et al.
Published: (2003)

Hypoxia Induced NF-κB
by: D’Ignazio, Laura, et al.
Published: (2016)

NF-κB-Mediated Regulation of Osteoclastogenesis
by: Boyce, Brendan F., et al.
Published: (2015)

Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent
by: Samy, R., et al.
Published: (2015)

NF-κB regulation: the nuclear response
by: Mankan, Arun K, et al.
Published: (2009)

NF-κB in inflammation and renal diseases
by: Zhang, Haisong, et al.
Published: (2015)

The interaction between ER and NFκB in resistance to endocrine therapy
by: Sas, Leen, et al.
Published: (2012)

It's Got You Covered: Nf-κb in the Epidermis
by: Kaufman, Charles K., et al.
Published: (2000)

Paraptosis and NF-κB activation are associated with protopanaxadiol-induced cancer chemoprevention
by: Wang, Chong-Zhi, et al.
Published: (2013)

Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice
by: Shukla, Sanjeev, et al.
Published: (2015)

Single TNFα trimers mediating NF-κB activation: stochastic robustness of NF-κB signaling
by: Lipniacki, Tomasz, et al.
Published: (2007)

TXNIP/TRX/NF-κB and MAPK/NF-κB pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats
by: Bi, Qi-rui, et al.
Published: (2016)

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
by: Nishio, H, et al.
Published: (2014)

NF-κB Signaling in the Brain of Autistic Subjects
by: Malik, Mazhar, et al.
Published: (2011)

NF-κB Inhibitors from Eurycoma longifolia
by: Tran, Thi Van Anh, et al.
Published: (2014)

Disulfide-Mediated Stabilization of the IκB Kinase Binding Domain of NF-κB Essential Modulator (NEMO)
by: Zhou, Li, et al.
Published: (2014)

Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy
by: Zerbini, Luiz F., et al.
Published: (2011)

The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
by: Loukik Arora, et al.
Published: (2018-09-01)

NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
by: Uno, Masaya, et al.
Published: (2014)